Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C and vitamin D, prostate-specific antigens, sexually transmitted diseases, hepatitis C, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check test results; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governmental agencies, physicians and other healthcare providers, hospitals and health systems, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 is headquartered in Burlington, North Carolina.

UBS Tax-Opt Digital Transformation theme

UBS HV Tax-Opt Global Selections - Agg

Fidelity 500 Index

iShares Core S&P 500 ETF

Diamond Hill Large Cap Inv

Vanguard Value Index Inv

Fidelity Low-Priced Stock

Invesco S&P 500® Equal Weight ETF

The Health Care Select Sector SPDR® ETF

Vanguard Mid-Cap Value ETF

JPM US Mid Cap Value-Composite

JPMorgan Mid Cap Value L

Vanguard Total Stock Mkt Idx Inv

Vanguard Institutional 500 Index Trust

Vanguard Mid Cap Index Institutional

Allspring Special Mid Cap Value Inst

Diamond Hill Large Cap Equity

Allspring Special US Mid Cap Value Eq

BlackRock Equity Dividend Instl

SPDR® S&P 500® ETF Trust

Vanguard Group Inc

BlackRock Inc

Dimensional Fund Advisors, Inc.

Amvescap Plc.

Veritas Investment Partners (UK) Ltd.

Bank of America Corp

NORGES BANK

Northern Trust Corp

Nordea Investment Mgmt Bank Demark A/s

Cooke & Bieler LP

UBS Asset Mgmt Americas Inc

American Century Companies Inc

State Street Corp

Diamond Hill Capital Management Inc

Geode Capital Management, LLC

JPMorgan Chase & Co

Allspring Global Investments Holdings, LLC

Bank of New York Mellon Corp

FMR Inc

Morgan Stanley - Brokerage Accounts

Laboratory Corporation of America Holdings

Mr. Adam H. Schechter

President, CEO & Chairman

Mr. Mark S. Schroeder

Executive VP, President of Diagnostics Laboratories & COO

Dr. Brian J. Caveney J.D., M.D., M.P.H.

EVP, President of Early Development Research Laboratories and Chief Medical & Scientific Officer

LH's next earnings is on February 13, 2025 (Before Market Open)

LH's latest dividend is 0.72 USD on August 29, 2024

Laboratory Corporation of America Holdings (LH) Stock Analysis, Discussion Forum and Financial Metrics - NYSE Exchange

Laboratory Corporation of America Holdings (LH) Earnings Report Date and History | NYSE

LH's next earnings is on February 13, 2025 (Before Market Open)

When is the earnings report for LH?

LH Earnings History

LH's latest dividend is 0.72 USD on August 29, 2024

LH Stock Discussion Forum and Message Board

News for NYSE: LH